...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark.
【24h】

Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark.

机译:取消使用抗菌剂促进生长对丹麦食用动物粪便肠球菌中抗菌素耐药性的影响。

获取原文
获取原文并翻译 | 示例

摘要

From 1995 to 2000, a total of 673 Enterococcus faecium and 1,088 Enterococcus faecalis isolates from pigs together with 856 E. faecium isolates from broilers were isolated and tested for susceptibility to four classes of antimicrobial agents used for growth promotion as part of the Danish program of monitoring for antimicrobial resistance. The four antimicrobials were avilamycin, erythromycin, vancomycin, and virginiamycin. Major changes in the use of antimicrobial agents for growth promotion have occurred during the last 6 years in Denmark. The government banned the use of avoparcin in 1995 and of virginiamycin in 1998. Furthermore, the producers have voluntarily stopped all use beginning in 1999. The avoparcin ban in 1995 was followed by a decrease in the occurrence of glycopeptide-resistant E. faecium (GRE) in broilers, from 72.7% in 1995 to 5.8% in 2000. The occurrence of glycopeptide resistance among isolates from pigs remained constant at around 20% from 1995 to 1997. It was shown that, in GRE from pigs, the genes encoding macrolide and glycopeptide resistance were genetically linked and that, following the decrease in the use of tylosin during 1998 and 1999, the occurrence of GRE in pigs decreased to 6.0% in 2000. From 1995 to 1997 the occurrence of erythromycin resistance among E. faecium and E. faecalis isolates from pigs was almost 90%. Use of tylosin decreased considerably during 1998 and 1999, and this decrease was followed by decreases in the occurrence of resistance to 46.7 and 28.1% among E. faecium and E. faecalis isolates from pigs, respectively. Erythromycin resistance among E. faecium isolates from broilers reached a maximum of 76.3% in 1997 but decreased to 12.7% in 2000 concomitantly with more limited use of virginiamycin. Use of virginiamycin increased from 1995 to 1997 and was followed by an increased occurrence of virginiamycin resistance among E. faecium isolates in broilers, from 27.3% in 1995 to 66.2% in 1997. In January 1998 the use of virginiamycin was banned in Denmark, and the occurrence of virginiamycin resistance decreased to 33.9% in 2000. Use of avilamycin increased from 1995 to 1996 and was followed by an increase in avilamycin resistance among E. faecium isolates from broilers, from 63.6% in 1995 to 77.4% in 1996. Since 1996 avilamycin usage has decreased, followed by a decrease in resistance to 4.8% in 2000. Our observations show that it is possible to reduce the occurrence of antimicrobial resistance in a national population of food animals when the selective pressure is removed. Cases in which resistance to vancomycin was linked to resistance to erythromycin were exceptions. In such cases resistance did not decrease until the use of both avoparcin and tylosin was limited.
机译:从1995年到2000年,共分离了来自猪的673株粪肠球菌和1088株粪肠球菌,以及来自肉鸡的856株粪肠球菌,并测试了作为丹麦计划的一部分用于促进生长的四类抗菌剂的敏感性。监测抗菌素耐药性。四种抗微生物药是阿维霉素,红霉素,万古霉素和维吉尼亚霉素。在过去的6年中,丹麦使用抗菌剂促进生长的方式发生了重大变化。政府于1995年禁止使用阿沃帕星,1998年禁止使用维吉尼亚霉素。此外,生产商自1999年开始自愿停止使用所有药物。1995年禁止阿沃帕星,其后出现了对糖肽耐药的屎肠球菌(GRE。 ),从1995年的72.7%下降到2000年的5.8%。从猪中分离出的糖肽耐药性在1995年至1997年期间保持恒定在20%左右。研究表明,在猪的GRE中,编码大环内酯和糖肽耐药性具有遗传相关性,并且随着1998和1999年泰乐菌素使用量的减少,猪中GRE的发生率在2000年下降到6.0%。从1995年到1997年,粪肠球菌和大肠杆菌中红霉素的耐药性发生。猪粪中分离出的粪便几乎占90%。在1998年和1999年期间,泰乐菌素的使用量大大减少,随后,猪的粪肠球菌和粪肠球菌分离株的耐药性分别下降到46.7和28.1%。肉仔鸡粪便中分离出的红霉素的抗性在1997年达到最高76.3%,但在2000年下降到12.7%,与此同时,弗吉尼亚霉素的使用受到限制。从1995年到1997年,维吉尼亚霉素的使用有所增加,随后肉鸡大肠杆菌分离株中维吉尼亚霉素的耐药性发生率也从1995年的27.3%上升到1997年的66.2%。1998年1月,丹麦禁止使用维吉霉素,并且2000年,维吉尼亚霉素耐药性的发生率下降到33.9%。从1995年到1996年,阿维拉霉素的使用量增加,其次是从肉鸡身上分离的粪肠球菌对阿维拉霉素的耐药性从1995年的63.6%增加到1996年的77.4%。自1996年以来阿维霉素的使用量减少了,其耐药性在2000年下降到4.8%。我们的观察结果表明,去除选择压力后,有可能减少全国食用动物种群中的抗菌素耐药性的发生。对万古霉素的耐药性与对红霉素的耐药性有关的病例除外。在这种情况下,直到限制使用阿伏霉素和泰乐菌素,耐药性才会降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号